Skip to main content
Clinical Trials/KCT0002894
KCT0002894Completed未知

The efficacy of topical bupivacaine and triamcinolone acetonide submucosal injection for pain relief after endoscopic submucosal dissection: a randomized double-blind, placebo-controlled multi-center trial

Hallym University Medical Center-Dongtan0 sites86 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
86

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
20(Year) to o Limit (—)
Sex
All

Inclusion Criteria

  • We prospectively evaluated consecutive patients with ages of 20 or older who were scheduled to undergo ESD for pathologically diagnosed or clinically suspected gastric adenoma or cancer at Hallym medical center.

Exclusion Criteria

  • (1) declining to provide informed consent; (2) American Society of Anesthesiology risk Class 3 or higher; (3) severe hepatic disease or cardiopulmonary or renal dysfunction; (4) current analgesics including non-steroidal anti-inflammatory drug use during the preceding week; (5) allergy to bupivacaine or other amide-type local anesthesia; (6) confirmation of any other disease that could induce abdominal pain similar with post-ESD pain; (7) presence of multiple lesions requiring endoscopic resection in one patient; (8) current pregnancy or breast feeding; (9) impossible to assess pain such as severe psychiatric or neurologic disease.

Investigators

Sponsor
Hallym University Medical Center-Dongtan

Similar Trials